Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study
2016-01-01 Bagnoli, M; Canevari, S; Califano, D; Losito, S; Di Maio, M; Raspagliesi, F; Carcangiu, Ml; Toffoli, G; Cecchin, E; Sorio, R; Canzonieri, V; Russo, D; Scognamiglio, G; Chiappetta, G; Baldassarre, G; Lorusso, D; Scambia, G; Zannoni, Gf; Savarese, A; Carosi, M; Scollo, P; Breda, E; Murgia, V; Perrone, F; Pignata, S; De Cecco, L; Mezzanzanica, D
Does rhythm or rate control strategy influence anticoagulant treatment in older patients with atrial fibrillation? Data from REPOSI
2017-01-01 Damanti, S.; Cortesi, L.; Pasina, L.; Mari, D.; Marcucci, M.
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer
2019-01-01 Pignata, S; Scambia, G; Lorusso, D; De Giorgi, U; Nicoletto, Mo; Lauria, R; Mosconi, Am; Sacco, C; Omarini, C; Tagliaferri, P; Ferrandina, G; Cinieri, S; Savarese, A; Valabrega, G; Pisano, C; Salutari, V; Raspagliesi, F; Kopf, B; Cecere, Sc; Amadio, G; Maltese, G; Di Napoli, M; Greggi, S; Signoriello, S; Daniele, G; Sacco, A; Losito, S; Normanno, N; Perrone, F; Gallo, C; Piccirillo, Mc; Mito, Investigators.
Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients
2012-01-01 Marengoni, A.; Bianchi, G.; Nobili, A.; Tettamanti, M.; Pasina, L.; Corrao, S.; Salerno, F.; Iorio, A.; Marcucci, M.; Mannucci, P. M.
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial
2021-01-01 Di Liello, R; Arenare, L; Raspagliesi, F; Scambia, G; Pisano, C; Colombo, N; Frezzini, S; Tognon, G; Artioli, G; Gadducci, A; Lauria, R; Ferrero, A; Cinieri, S; De Censi, A; Breda, E; Scollo, P; De Giorgi, U; Lissoni, Aa; Katsaros, D; Lorusso, D; Salutari, V; Cecere, Sc; Lapresa, M; Nardin, M; Bogani, G; Distefano, M; Greggi, S; Gargiulo, P; Schettino, C; Gallo, C; Daniele, G; Califano, D; Perrone, F; Pignata, S; Piccirillo, Mc
The addition of lymphadenectomy to secondary cytoreductive surgery in comparison with bulky node resection in patients with recurrent ovarian cancer
2018-01-01 Bogani, G; Leone Roberti Maggiore, U; Chiappa, V; Ditto, A; Martinelli, F; Sabatucci, I; Mosca, L; Lorusso, D; Raspagliesi, F
Photodynamic therapy with M-ALA as non surgical treatment option in patients with primary extramammary Paget's disease
2013-01-01 Fontanelli, R; Papadia, A; Martinelli, F; Lorusso, D; Grijuela, B; Merola, M; Solima, E; Ditto, A; Raspagliesi, F
Treatment modalities for recurrent high-grade vaginal intraepithelial neoplasia
2019-01-01 Bogani, G; Ditto, A; Ferla, S; Paolini, B; Lombardo, C; Lorusso, D; Raspagliesi, F.
Recurrent granulosa cell tumors (GCTs) of the ovary: A MITO-9 retrospective study
2013-01-01 Mangili, G; Sigismondi, C; Frigerio, L; Candiani, M; Savarese, A; Giorda, G; Lauria, R; Tamberi, S; Greggi, S; Lorusso, D
Risk factors for hospital readmission of elderly patients
2013-01-01 Franchi, C.; Nobili, A.; Mari, D.; Tettamanti, M.; Djade, C. D.; Pasina, L.; Salerno, F.; Corrao, S.; Marengoni, A.; Iorio, A.; Marcucci, M.; Mannucci, P. M.; Selmi, C.; Investigators, Reposi
Pegylated liposomal doxorubicin re-challenge in patients with ovarian cancer relapse: a multicenter retrospective study
2019-01-01 Tripodi, E; Cormio, G; De Giorgi, U; Valabrega, G; Rubino, D; Lepori, S; Maltese, G; Sabatucci, I; Lorusso, D
Risk-reducing surgery on the uterine adnexa: timing and type of surgical treatment, and pathology report
2016-01-01 Signorelli, M; Bogani, G; Ditto, A; Martinelli, F; Chiappa, V; Lopez, C; Scaffa, C; Lorusso, D; Raspagliesi, F
A generalised model for individualising a treatment recommendation based on group-level evidence from randomised clinical trials
2013-01-01 Marcucci, M.; Sinclair, J. C.
Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors
2021-01-01 Nero, C; Ciccarone, F; Pietragalla, A; Duranti, S; Daniele, G; Salutari, V; Carbone, Mv; Scambia, G; Lorusso, D
Influenza vaccination and vitamin K antagonist treatment : a placebo-controlled, randomized, double-blind crossover study
2010-01-01 Iorio, A.; Basileo, M.; Marcucci, M.; Guercini, F.; Camilloni, B.; Paccamiccio, E.; Vecchioli, M.; Iorio, A. M.
Risk of recurrence after a first unprovoked venous thromboembolism : external validation of the Vienna Prediction Model with pooled individual patient data
2015-01-01 Marcucci, M.; Iorio, A.; Douketis, J. D.; Eichinger, S.; Tosetto, A.; Baglin, T.; Cushman, M.; Palareti, G.; Poli, D.; Tait, R. C.; Kyrle, P. A.
Gemcitabine (GEM) and liposomal doxorubicin (PLO) in recurrent/metastatic breast carcinoma: A phase II study
2005-01-01 Adamo, V; Ferrandina, G; Spada, M; Ferrau, F; Condemi, G; Di Lullo, L; Lorusso, D; Rossello, R; Garipoli, C; Scambia, G
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19)
2016-01-01 Marchetti, C; Ferrandina, G; Cormio, G; Gambino, A; Cecere, S; Lorusso, D; De Giorgi, U; Bogliolo, S; Fagotti, A; Mammoliti, S; Narducci, F; Bergamini, A; Scollo, P; Biglia, N; Breda, E; Tamberi, S; Marinaccio, M; Angioli, R; Salerno, L; Eusebi, Mc; Loizzi, V; Scambia, G; Panici, Pb
A tutorial on sensitivity analyses in clinical trials : the what, why, when and how
2013-01-01 Thabane, L.; Mbuagbaw, L.; Zhang, S.; Samaan, Z.; Marcucci, M.; Ye, C.; Thabane, M.; Giangregorio, L.; Dennis, B.; Kosa, D.; Borg Debono, V.; Dillenburg, R.; Fruci, V.; Bawor, M.; Lee, J.; Wells, G.; Goldsmith, C. H.
MALIGNANT ASCITES IN CLINICAL PRACTICE: AIOM FOUNDATION SURVEY
2009-01-01 Petrelli, Fausto; Lorusso, D; Bajetta, Emilio; Barni, Sandro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study | 1-gen-2016 | Bagnoli, M; Canevari, S; Califano, D; Losito, S; Di Maio, M; Raspagliesi, F; Carcangiu, Ml; Toffoli, G; Cecchin, E; Sorio, R; Canzonieri, V; Russo, D; Scognamiglio, G; Chiappetta, G; Baldassarre, G; Lorusso, D; Scambia, G; Zannoni, Gf; Savarese, A; Carosi, M; Scollo, P; Breda, E; Murgia, V; Perrone, F; Pignata, S; De Cecco, L; Mezzanzanica, D | |
| Does rhythm or rate control strategy influence anticoagulant treatment in older patients with atrial fibrillation? Data from REPOSI | 1-gen-2017 | Damanti, S.; Cortesi, L.; Pasina, L.; Mari, D.; Marcucci, M. | |
| The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer | 1-gen-2019 | Pignata, S; Scambia, G; Lorusso, D; De Giorgi, U; Nicoletto, Mo; Lauria, R; Mosconi, Am; Sacco, C; Omarini, C; Tagliaferri, P; Ferrandina, G; Cinieri, S; Savarese, A; Valabrega, G; Pisano, C; Salutari, V; Raspagliesi, F; Kopf, B; Cecere, Sc; Amadio, G; Maltese, G; Di Napoli, M; Greggi, S; Signoriello, S; Daniele, G; Sacco, A; Losito, S; Normanno, N; Perrone, F; Gallo, C; Piccirillo, Mc; Mito, Investigators. | |
| Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients | 1-gen-2012 | Marengoni, A.; Bianchi, G.; Nobili, A.; Tettamanti, M.; Pasina, L.; Corrao, S.; Salerno, F.; Iorio, A.; Marcucci, M.; Mannucci, P. M. | |
| Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial | 1-gen-2021 | Di Liello, R; Arenare, L; Raspagliesi, F; Scambia, G; Pisano, C; Colombo, N; Frezzini, S; Tognon, G; Artioli, G; Gadducci, A; Lauria, R; Ferrero, A; Cinieri, S; De Censi, A; Breda, E; Scollo, P; De Giorgi, U; Lissoni, Aa; Katsaros, D; Lorusso, D; Salutari, V; Cecere, Sc; Lapresa, M; Nardin, M; Bogani, G; Distefano, M; Greggi, S; Gargiulo, P; Schettino, C; Gallo, C; Daniele, G; Califano, D; Perrone, F; Pignata, S; Piccirillo, Mc | |
| The addition of lymphadenectomy to secondary cytoreductive surgery in comparison with bulky node resection in patients with recurrent ovarian cancer | 1-gen-2018 | Bogani, G; Leone Roberti Maggiore, U; Chiappa, V; Ditto, A; Martinelli, F; Sabatucci, I; Mosca, L; Lorusso, D; Raspagliesi, F | |
| Photodynamic therapy with M-ALA as non surgical treatment option in patients with primary extramammary Paget's disease | 1-gen-2013 | Fontanelli, R; Papadia, A; Martinelli, F; Lorusso, D; Grijuela, B; Merola, M; Solima, E; Ditto, A; Raspagliesi, F | |
| Treatment modalities for recurrent high-grade vaginal intraepithelial neoplasia | 1-gen-2019 | Bogani, G; Ditto, A; Ferla, S; Paolini, B; Lombardo, C; Lorusso, D; Raspagliesi, F. | |
| Recurrent granulosa cell tumors (GCTs) of the ovary: A MITO-9 retrospective study | 1-gen-2013 | Mangili, G; Sigismondi, C; Frigerio, L; Candiani, M; Savarese, A; Giorda, G; Lauria, R; Tamberi, S; Greggi, S; Lorusso, D | |
| Risk factors for hospital readmission of elderly patients | 1-gen-2013 | Franchi, C.; Nobili, A.; Mari, D.; Tettamanti, M.; Djade, C. D.; Pasina, L.; Salerno, F.; Corrao, S.; Marengoni, A.; Iorio, A.; Marcucci, M.; Mannucci, P. M.; Selmi, C.; Investigators, Reposi | |
| Pegylated liposomal doxorubicin re-challenge in patients with ovarian cancer relapse: a multicenter retrospective study | 1-gen-2019 | Tripodi, E; Cormio, G; De Giorgi, U; Valabrega, G; Rubino, D; Lepori, S; Maltese, G; Sabatucci, I; Lorusso, D | |
| Risk-reducing surgery on the uterine adnexa: timing and type of surgical treatment, and pathology report | 1-gen-2016 | Signorelli, M; Bogani, G; Ditto, A; Martinelli, F; Chiappa, V; Lopez, C; Scaffa, C; Lorusso, D; Raspagliesi, F | |
| A generalised model for individualising a treatment recommendation based on group-level evidence from randomised clinical trials | 1-gen-2013 | Marcucci, M.; Sinclair, J. C. | |
| Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors | 1-gen-2021 | Nero, C; Ciccarone, F; Pietragalla, A; Duranti, S; Daniele, G; Salutari, V; Carbone, Mv; Scambia, G; Lorusso, D | |
| Influenza vaccination and vitamin K antagonist treatment : a placebo-controlled, randomized, double-blind crossover study | 1-gen-2010 | Iorio, A.; Basileo, M.; Marcucci, M.; Guercini, F.; Camilloni, B.; Paccamiccio, E.; Vecchioli, M.; Iorio, A. M. | |
| Risk of recurrence after a first unprovoked venous thromboembolism : external validation of the Vienna Prediction Model with pooled individual patient data | 1-gen-2015 | Marcucci, M.; Iorio, A.; Douketis, J. D.; Eichinger, S.; Tosetto, A.; Baglin, T.; Cushman, M.; Palareti, G.; Poli, D.; Tait, R. C.; Kyrle, P. A. | |
| Gemcitabine (GEM) and liposomal doxorubicin (PLO) in recurrent/metastatic breast carcinoma: A phase II study | 1-gen-2005 | Adamo, V; Ferrandina, G; Spada, M; Ferrau, F; Condemi, G; Di Lullo, L; Lorusso, D; Rossello, R; Garipoli, C; Scambia, G | |
| Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) | 1-gen-2016 | Marchetti, C; Ferrandina, G; Cormio, G; Gambino, A; Cecere, S; Lorusso, D; De Giorgi, U; Bogliolo, S; Fagotti, A; Mammoliti, S; Narducci, F; Bergamini, A; Scollo, P; Biglia, N; Breda, E; Tamberi, S; Marinaccio, M; Angioli, R; Salerno, L; Eusebi, Mc; Loizzi, V; Scambia, G; Panici, Pb | |
| A tutorial on sensitivity analyses in clinical trials : the what, why, when and how | 1-gen-2013 | Thabane, L.; Mbuagbaw, L.; Zhang, S.; Samaan, Z.; Marcucci, M.; Ye, C.; Thabane, M.; Giangregorio, L.; Dennis, B.; Kosa, D.; Borg Debono, V.; Dillenburg, R.; Fruci, V.; Bawor, M.; Lee, J.; Wells, G.; Goldsmith, C. H. | |
| MALIGNANT ASCITES IN CLINICAL PRACTICE: AIOM FOUNDATION SURVEY | 1-gen-2009 | Petrelli, Fausto; Lorusso, D; Bajetta, Emilio; Barni, Sandro |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista27918
Data di pubblicazione
- In corso di stampa14
- 2020 - 20269653
- 2010 - 201911835
- 2000 - 20094579
- 1990 - 19991485
- 1980 - 1989329
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE372
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...267
- ANNALS OF ONCOLOGY244
- CANCERS232
- PLOS ONE223
- THE JOURNAL OF NUCLEAR MEDICINE222
- JOURNAL OF CLINICAL MEDICINE215
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY197
- ALLERGY180
Keyword
- Humans2166
- Female1035
- Male996
- Middle Aged767
- Aged669
- Adult559
- COVID-19442
- Treatment Outcome373
- Animals329
- Retrospective Studies264
Lingua
- eng19972
- ita459
- spa14
- fre11
- ger8
- enm4
- por2
- chi1
Accesso al fulltext
- no fulltext25665
- reserved1362
- open891